Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor site update. This does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4. This indicates the study record has been updated to a newer revision of the page content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the clinical trial study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedLocation entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.